286 related articles for article (PubMed ID: 24285541)
1. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
[TBL] [Abstract][Full Text] [Related]
2. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
3. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C
Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672
[TBL] [Abstract][Full Text] [Related]
4. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of ligand binding modes at the human formyl peptide receptor 2.
Chen T; Xiong M; Zong X; Ge Y; Zhang H; Wang M; Won Han G; Yi C; Ma L; Ye RD; Xu Y; Zhao Q; Wu B
Nat Commun; 2020 Mar; 11(1):1208. PubMed ID: 32139677
[TBL] [Abstract][Full Text] [Related]
6. The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations.
Yuan S; Ghoshdastider U; Trzaskowski B; Latek D; Debinski A; Pulawski W; Wu R; Gerke V; Filipek S
PLoS One; 2012; 7(11):e47114. PubMed ID: 23189124
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
Schmitz Nunes V; Rogério AP; Abrahão O
J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
[TBL] [Abstract][Full Text] [Related]
8. Structural Determinants in the
Viklund M; Fredriksson J; Holdfeldt A; Lind S; Franzyk H; Dahlgren C; Sundqvist M; Forsman H
J Immunol; 2022 Apr; 208(7):1632-1641. PubMed ID: 35321878
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
Arch Biochem Biophys; 2011 Dec; 516(2):121-7. PubMed ID: 22005393
[TBL] [Abstract][Full Text] [Related]
10. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
Kretschmer D; Rautenberg M; Linke D; Peschel A
J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and characterization of fMLF-mimicking AApeptides.
Hu Y; Cheng N; Wu H; Kang S; Ye RD; Cai J
Chembiochem; 2014 Nov; 15(16):2420-6. PubMed ID: 25224835
[TBL] [Abstract][Full Text] [Related]
12. The formyl peptide fMLF primes platelet activation and augments thrombus formation.
Salamah MF; Ravishankar D; Vaiyapuri R; Moraes LA; Patel K; Perretti M; Gibbins JM; Vaiyapuri S
J Thromb Haemost; 2019 Jul; 17(7):1120-1133. PubMed ID: 31033193
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.
Forsman H; Andréasson E; Karlsson J; Boulay F; Rabiet MJ; Dahlgren C
J Immunol; 2012 Jul; 189(2):629-37. PubMed ID: 22706076
[TBL] [Abstract][Full Text] [Related]
14. Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.
Stepniewski TM; Filipek S
Bioorg Med Chem; 2015 Jul; 23(14):4072-81. PubMed ID: 25882522
[TBL] [Abstract][Full Text] [Related]
15. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
16. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors.
Quehenberger O; Prossnitz ER; Cavanagh SL; Cochrane CG; Ye RD
J Biol Chem; 1993 Aug; 268(24):18167-75. PubMed ID: 8349692
[TBL] [Abstract][Full Text] [Related]
17. N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
Rabiet MJ; Macari L; Dahlgren C; Boulay F
J Biol Chem; 2011 Jul; 286(30):26718-31. PubMed ID: 21543323
[TBL] [Abstract][Full Text] [Related]
18.
Korimová A; Dubový P
Cells; 2020 Dec; 9(12):. PubMed ID: 33322305
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.
Khlebnikov AI; Schepetkin IA; Kirpotina LN; Brive L; Dahlgren C; Jutila MA; Quinn MT
J Mol Model; 2012 Jun; 18(6):2831-43. PubMed ID: 22127612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]